ICIG has made management changes to its contract manufacturing business, CordenPharma, which will operate two business groups, APIs and Drug Products. The two businesses will continue to report to CordenPharma’s president Dr. Wolfgang Niedermaier.   Dr. Karsten Benzing, currently executive principal at ICIG S.E., will also serve as chief operating officer of the CordenPharma Drug Product business, overseeing CordenPharma Caponago, CordenPharma Latina and CordenPharma Plankstadt.   Dr. Christian ...